CD8A and neoplasm: We found that Tα1 promoted the tumor infiltration of CD8+ cells, thus increasing the tumor immunoscore, now considered a marker of improved overall survival in response to ICI (Pages et al, 2018; Kumpers et al, 2019; Angell et al, 2020).